A survey of >15 000 UK respondents found people who have or had COVID-19 are more likely to develop general psychiatric disorders and loneliness.
Ketamine used in patients with treatment-resistant depression operates via serotonin 1B receptors by way of a previously unknown mechanism of action, according to a new study from Sweden.
Over half of US adults who responded to a new survey said COVID-19 has impacted their mental health. To what extent? Find out in our new slideshow.